Targeting the PI3K-Akt pathway in human cancer
Top Cited Papers
- 1 October 2003
- journal article
- review article
- Published by Elsevier in Cancer Cell
- Vol. 4 (4) , 257-262
- https://doi.org/10.1016/s1535-6108(03)00248-4
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- United at last: the tuberous sclerosis complex gene products connect the phosphoinositide 3-kinase/Akt pathway to mammalian target of rapamycin (mTOR) signallingBiochemical Society Transactions, 2003
- HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cellsOncogene, 2003
- Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitorsOncogene, 2003
- Crystal structure of an activated Akt/Protein Kinase B ternary complex with GSK3-peptide and AMP-PNPNature Structural & Molecular Biology, 2002
- Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomasNature Genetics, 2002
- The Phosphoinositide 3-Kinase PathwayScience, 2002
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancersNature Genetics, 1997
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997